Study of DF6215 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
Dragonfly Therapeutics
ViroMissile, Inc.
Tizona Therapeutics, Inc
IDEAYA Biosciences
Adaptimmune
Oscotec Inc.
Novartis
Pfizer
National Institutes of Health Clinical Center (CC)
Bolt Biotherapeutics, Inc.
Actym Therapeutics, Inc.
Exelixis
MacroGenics
Incyte Corporation
Genentech, Inc.
DEKA Biosciences
Columbia University
Revolution Medicines, Inc.
Checkpoint Therapeutics, Inc.
Carisma Therapeutics Inc
Acepodia Biotech, Inc.
Inhibrx Biosciences, Inc
The Affiliated Hospital of Qingdao University
Xencor, Inc.
Pfizer
Celldex Therapeutics
STCube, Inc.
Adaptimmune
Apexigen America, Inc.
Centre Georges Francois Leclerc
Emory University
Fate Therapeutics
Mabpro, a.s.
Mirati Therapeutics Inc.
Quadriga Biosciences, Inc.
Xencor, Inc.
Ludwig Institute for Cancer Research
Revolution Medicines, Inc.
Imperial College London
Pfizer
Incyte Corporation
Five Prime Therapeutics, Inc.
MacroGenics
Weill Medical College of Cornell University
Shionogi Inc.
Bayer
Tocagen Inc.
MedImmune LLC
Celldex Therapeutics
University Health Network, Toronto